Original Source(s)
Related Content
FDA approves serial liquid biopsy testing
In SERENA-6, patients who changed treatment following detection of an ESR1 mutation had a 56% lower risk of disease progression or death.
September 8, 2026
-
2 min
AI cuts lesion measurement time by 34%
Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.
September 3, 2026
-
4 min
Inside the hip osteoarthritis microbiome
Investigators compared intra-articular microbial profiles and predicted metabolic pathways in patients with hip osteoarthritis and nonarthritic controls.
September 4, 2026
-
3 min
